A California medical institute may be funding a ground-breaking project, potentially increasing clinical research hiring in the area.
The Los Angeles Times reports that the California Institute for Regenerative Medicine (CIRM) will soon vote on a measure that could lead to funding for studies of a treatment derived from stem cells. According to the news source, CIRM was created by a ballot measure and charged with investing $3 billion in stem cell research.
If the CIRM decides to fund the clinical trial it would be significant as the news source reports that previously the entity had focused on providing money to scientists studying stem cells, which some believe could hold the key to finding cures for diseases like ALS and multiple sclerosis that had previously been considered incurable.
Clinical research hiring may not be only picking up in California but Michigan as well. Adeona Pharmaceuticals, Inc. recently announced that it received about $1.6 million in funding from the National Institutes of Health/National Institute of Neurological Disorders and Stroke for its testing of the multiple sclerosis drug Trimesta.
This additional money may lead to the creation of more clinical research positions for the trial.